Work

Clinical treatment of tubal pregnancy with methotrexate: a comparison of intramuscular and intravenous routes in a randomized clinical trial

Year: 2026
Type: article
Abstract: Objective: To compare the intravenous and intramuscular administration routes of methotrexate in the clinical treatment of tubal pregnancy. Methods: A prospective randomized clinical trial was conducted, including women with an indication for medical management of tubal pregnancy, comparing the use of methotrexate via intravenous and intramuscular routes (50 mg/m² of body surface area). The analyzed outcome was treatment success (good outcome), defined as a 15% decrease in β-hCG levels between days 1 and 7. Treatment failure was defined as the need for surgical intervention due to suspicion or confirmation of ruptured tubal pregnancy. Results: A total of 107 cases of tubal pregnancy were included, divided into the intravenous group (n = 48) and the intramuscular group (n = 59). The mean age of the women was 28.1 years (range, 18-40). The mean mass size was 21.8 mm (range, 7-49 mm), and the median [Q1-Q3] initial serum β-hCG value was 1361,15 mU/mL (584,58-2382,45). No significant differences were found between the groups regarding treatment success or failure outcomes, nor in adverse effects. The treatment success rates in the intravenous and intramuscular groups were 74.6% and 79.2%, respectively. Conclusion: The intravenous and intramuscular routes for the clinical treatment of tubal pregnancy with methotrexate were equivalent in treatment success outcomes, with no difference observed in the reduction of serum β-hCG levels. Brazilian Clinical Trials Registry ReBEC: # RBR-7nkf8tn.
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7225698989
FWCI:
Cites: 11
Cited by:
Related to: 10